This site is intended for healthcare professionals only


Diabetes Digest

Issue:

Share this article

British children among the least active in the world

Damning research by the Active Healthy Kids Global Alliance, a network of researchers and health workers, has revealed that British children are among the least active in the world. Overall, England and Wales were both scored D−, the third worst grade in the rankings, while Scotland was joint worst, with a grade of F.

Damning research by the Active Healthy Kids Global Alliance, a network of researchers and health workers, has revealed that British children are among the least active in the world. Overall, England and Wales were both scored D−, the third worst grade in the rankings, while Scotland was joint worst, with a grade of F.

Dr Steven Mann, Research Director at UK Active, said that “Movement has been stripped out of modern living, meaning Generation Inactive are driven to school and fed a staple diet of sofa play and screen time, while being starved of outdoor activities.” His organisation is calling for Ofsted to rate schools on children’s fitness.

The Telegraph, 20 November 2016

Ten-minute walks after meals improve glycaemic control in type 2 diabetes
Taking a 10-minute stroll after each meal could help people with type 2 diabetes control their condition, according to research published in Diabetologia. People who walked after each meal had lower postprandial blood glucose levels than those who walked for 30 minutes per day independent of meal times.

The improvement was most striking after the evening meal, when the most carbohydrate was consumed and sedentary behaviours were highest, with a 22% relative reduction in the area under the blood glucose curve in the post-meal walking group.

Mail Online, 18 October 2016

Obesity and diabetes by middle age tied to heart failure later on
People who reach middle age without developing high blood pressure, diabetes or obesity may have a lower risk of heart failure later in life, according to a study published in the Journal of the American College of Cardiology: Heart Failure.

Over 516 537 person-years of follow-up, compared to people with all three of these risk factors, adults who had none of them by age 45 were 73% less likely to develop heart failure over the rest of their lifetime. They lived on average an additional 3–15 years free of heart failure than those with one or more risk factors. Controlling these risk factors when young appears to pay dividends in later life.

Reuters, 30 November 2016

Ban on advertising unhealthy food in all children’s media
The Committee of Advertising Practice has announced tough new rules banning the advertising of food and drink products high in fat, salt or sugar in children’s media. The rules will apply across all non-broadcast media, including print, cinema and, crucially, online and social media, bringing them in line with television rules.

The rules come in response to concerns about childhood obesity and shifting media habits amongst young people, with research from Ofcom showing that children aged 5–15 years spend around 15 hours per week online. The rules, which will apply to all media targeted at under-16s, will come into effect on 1 July 2017.

Diabetes UK, 8 December 2016

A new source of antidiabetes drugs: The platypus
Researchers in Australia have identified a novel form of glucagon-like peptide-1 (GLP-1), a gut hormone that stimulates insulin release, in the venom of the duck-billed platypus. This form of the hormone is resistant to degradation by dipeptidyl peptidase-4, and the discovery could pave the way to novel antidiabetes drugs similar to the GLP-1 receptor agonists that are currently available.

In addition to the version of GLP-1 found both in the human gut and in the guts of monotremes (mammals that include the platypus and the echidna), the longer-lasting form is found in a powerful venom produced by the platypus during mating season to fend off competing males.

“The function in venom has most likely triggered the evolution of a stable form of GLP-1 in monotremes,” said Briony Forbes, Associate Professor at Flinders University and co-lead author of the study. “Excitingly, stable GLP-1 molecules are highly desirable as potential type 2 diabetes treatments.” However, Professor Forbes was quick to point out that any resulting treatment would be a long way off.

BBC News, 30 November 2016

Related content
;
Free for all UK & Ireland healthcare professionals

Sign up to all DiabetesontheNet journals

 

By clicking ‘Subscribe’, you are agreeing that DiabetesontheNet.com are able to email you periodic newsletters. You may unsubscribe from these at any time. Your info is safe with us and we will never sell or trade your details. For information please review our Privacy Policy.

Are you a healthcare professional? This website is for healthcare professionals only. To continue, please confirm that you are a healthcare professional below.

We use cookies responsibly to ensure that we give you the best experience on our website. If you continue without changing your browser settings, we’ll assume that you are happy to receive all cookies on this website. Read about how we use cookies.